Shandong Sinobioway Biomedicine Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 224.324 million compared to CNY 135.955 million a year ago. Operating income was CNY 146.046 million compared to operating loss of CNY 102.271 million a year ago. Net income was CNY 137.921 million compared to net loss of CNY 92.352 million a year ago. Basic earnings per share from continuing operations was CNY 0.2091 compared to basic loss per share from continuing operations of CNY 0.14 a year ago.